Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,775 | -9,888 | -7,046 | -2,789 | -659 |
| Depreciation Amortization | 64 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 580 | 177 | 611 | -54 | -11 |
| Other Working Capital | 569 | 132 | 1,013 | 10 | -63 |
| Other Operating Activity | 2,502 | 1,753 | 1,781 | 709 | -1,129 |
| Operating Cash Flow | $-9,060 | $-7,826 | $-3,641 | $-2,124 | $-1,862 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $0 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 2,329 | 27,975 | 5,108 | 497 |
| Other Financing Activity | -71 | 18 | 0 | 0 | 0 |
| Financing Cash Flow | $-71 | $2,347 | $27,975 | $5,108 | $497 |
| Beginning Cash Position | 22,781 | 28,260 | 3,926 | 942 | 2,307 |
| End Cash Position | 13,650 | 22,781 | 28,260 | 3,926 | 942 |
| Net Cash Flow | $-9,131 | $-5,479 | $24,334 | $2,984 | $-1,365 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,060 | -7,826 | -3,641 | -2,124 | -1,862 |
| Free Cash Flow | -9,060 | -7,826 | -3,641 | -2,124 | -1,862 |